Lithium Citrate

   
Google
 
Web NewDrugInformation.com

Lithium Citrate


Drug - Lithium Citrate
The trade name of the product as shown on the labeling.

Dosage - SYRUP; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lithium Citrate
Multiple ingredients are in alphabetical order.

Strength - EQ 300MG CARBONATE/5ML
The potency of the active ingredient(s), Lithium Citrate. May repeat for multiple part products.

Applicant - ROXANE
The firm name holding legal responsibility for Lithium Citrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018421
The FDA assigned number to Lithium Citrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lithium Citrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Lithium Citrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lithium Citrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lithium Citrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Roxane Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Lithium Citrate.

Lithium Citrate